Predicting effect of novel treatments using molecular pathways and real-world data

• URL: http://arxiv.org/abs/2509.07204v1
• Date: Mon, 08 Sep 2025 20:35:15 GMT
• Title: Predicting effect of novel treatments using molecular pathways and real-world data
• Authors: Adrien Couetoux, Thomas Devenyns, Lise Diagne, David Champagne, Pierre-Yves Mousset, Chris Anagnostopoulos,
• Abstract summary: We propose a flexible and modular machine learning-based approach for predicting the efficacy of an untested pharmaceutical for treating a disease.<n>We train a machine learning model using sets of pharmaceutical-pathway weight impact scores and patient data.<n>The resulting model then analyses weighted impact scores of an untested pharmaceutical across human biological molecule-protein pathways to generate a predicted efficacy value.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: In pharmaceutical R&D, predicting the efficacy of a pharmaceutical in treating a particular disease prior to clinical testing or any real-world use has been challenging. In this paper, we propose a flexible and modular machine learning-based approach for predicting the efficacy of an untested pharmaceutical for treating a disease. We train a machine learning model using sets of pharmaceutical-pathway weight impact scores and patient data, which can include patient characteristics and observed clinical outcomes. The resulting model then analyses weighted impact scores of an untested pharmaceutical across human biological molecule-protein pathways to generate a predicted efficacy value. We demonstrate how the method works on a real-world dataset with patient treatments and outcomes, with two different weight impact score algorithms We include methods for evaluating the generalisation performance on unseen treatments, and to characterise conditions under which the approach can be expected to be most predictive. We discuss specific ways in which our approach can be iterated on, making it an initial framework to support future work on predicting the effect of untested drugs, leveraging RWD clinical data and drug embeddings.

Related papers

• Beyond the ATE: Interpretable Modelling of Treatment Effects over Dose and Time [46.2482873419289]
  We propose a framework for modelling treatment effect trajectories as smooth surfaces over dose and time.<n>Our approach decouples the estimation of trajectory shape from the specification of clinically relevant properties.<n>We show that our method yields accurate, interpretable, and editable models of treatment dynamics.
  arXiv  Detail & Related papers  (2025-07-09T20:33:33Z)
• Advancing clinical trial outcomes using deep learning and predictive modelling: bridging precision medicine and patient-centered care [0.0]
  Deep learning and predictive modelling have emerged as transformative tools for optimizing clinical trial design, patient recruitment, and real-time monitoring.<n>This study explores the application of deep learning techniques, such as convolutional neural networks [CNNs] and transformerbased models, to stratify patients.<n>Predictive modelling approaches, including survival analysis and time-series forecasting, are employed to predict trial outcomes, enhancing efficiency and reducing trial failure rates.
  arXiv  Detail & Related papers  (2024-12-09T23:20:08Z)
• Clustering of Disease Trajectories with Explainable Machine Learning: A Case Study on Postoperative Delirium Phenotypes [13.135589459700865]
  We propose an approach that combines supervised machine learning for personalized POD risk prediction with unsupervised clustering techniques to uncover potential POD phenotypes. We show that clustering patients in the SHAP feature importance space successfully recovers the true underlying phenotypes, outperforming clustering in the raw feature space.
  arXiv  Detail & Related papers  (2024-05-06T10:05:46Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• Enhancing Acute Kidney Injury Prediction through Integration of Drug Features in Intensive Care Units [0.0]
  The relationship between acute kidney injury (AKI) prediction and nephrotoxic drugs has yet to be explored in the critical care setting. This study proposes a novel approach that leverages patient prescription data as a modality to improve existing models for AKI prediction.
  arXiv  Detail & Related papers  (2024-01-09T05:42:32Z)
• Global Deep Forecasting with Patient-Specific Pharmacokinetics [14.550711449872512]
  We propose a novel hybrid global-local architecture and a PK encoder that informs deep learning models of patient-specific treatment effects.<n>We showcase the efficacy of our approach in achieving significant accuracy gains in a blood glucose forecasting task.
  arXiv  Detail & Related papers  (2023-09-22T18:43:41Z)
• Prediction of drug effectiveness in rheumatoid arthritis patients based on machine learning algorithms [2.5759046095742453]
  Rheumatoid arthritis (RA) is an autoimmune condition caused when patients' immune system mistakenly targets their own tissue. Machine learning (ML) has the potential to identify patterns in patient electronic health records to forecast the best clinical treatment to improve patient outcomes. This study introduced a Drug Response Prediction (TNF) framework with two main goals: 1) design a data processing pipeline to extract information from clinical data, and then preprocess it for functional use, and 2) predict RA patient's responses to drugs and evaluate classification models' performance.
  arXiv  Detail & Related papers  (2022-10-14T15:15:37Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Disentangled Counterfactual Recurrent Networks for Treatment Effect Inference over Time [71.30985926640659]
  We introduce the Disentangled Counterfactual Recurrent Network (DCRN), a sequence-to-sequence architecture that estimates treatment outcomes over time. With an architecture that is completely inspired by the causal structure of treatment influence over time, we advance forecast accuracy and disease understanding. We demonstrate that DCRN outperforms current state-of-the-art methods in forecasting treatment responses, on both real and simulated data.
  arXiv  Detail & Related papers  (2021-12-07T16:40:28Z)
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data [56.53715632642495]
  Clinical trials face uncertain outcomes due to issues with efficacy, safety, or problems with patient recruitment. In this paper, we propose Hierarchical INteraction Network (HINT) for more general, clinical trial outcome predictions.
  arXiv  Detail & Related papers  (2021-02-08T15:09:07Z)
• Clinical Outcome Prediction from Admission Notes using Self-Supervised Knowledge Integration [55.88616573143478]
  Outcome prediction from clinical text can prevent doctors from overlooking possible risks. Diagnoses at discharge, procedures performed, in-hospital mortality and length-of-stay prediction are four common outcome prediction targets. We propose clinical outcome pre-training to integrate knowledge about patient outcomes from multiple public sources.
  arXiv  Detail & Related papers  (2021-02-08T10:26:44Z)
• Trajectories, bifurcations and pseudotime in large clinical datasets: applications to myocardial infarction and diabetes data [94.37521840642141]
  We suggest a semi-supervised methodology for the analysis of large clinical datasets, characterized by mixed data types and missing values. The methodology is based on application of elastic principal graphs which can address simultaneously the tasks of dimensionality reduction, data visualization, clustering, feature selection and quantifying the geodesic distances (pseudotime) in partially ordered sequences of observations.
  arXiv  Detail & Related papers  (2020-07-07T21:04:55Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.